Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Cash from Operations (2019 - 2026)

InMed Pharmaceuticals has reported Cash from Operations over the past 5 years, most recently at 2376243.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 5.03% year-over-year to 2376243.0; the TTM value through Dec 2025 reached 7421862.0, down 1.77%, while the annual FY2025 figure was 7766951.0, 11.18% down from the prior year.
  • Cash from Operations for Q4 2025 was 2376243.0 at InMed Pharmaceuticals, down from 1607616.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 657934.0 in Q2 2023 and troughed at 5348786.0 in Q1 2022.
  • A 5-year average of 2311311.06 and a median of 2054267.5 in 2023 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: surged 83.74% in 2023 and later crashed 72.81% in 2025.
  • Year by year, Cash from Operations stood at 3533808.0 in 2021, then rose by 23.22% to 2713096.0 in 2022, then skyrocketed by 31.88% to 1848133.0 in 2023, then crashed by 35.39% to 2502138.0 in 2024, then rose by 5.03% to 2376243.0 in 2025.
  • Business Quant data shows Cash from Operations for INM at 2376243.0 in Q4 2025, 1607616.0 in Q3 2025, and 1778506.0 in Q2 2025.